The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Arcutis Biotherapeutics Inc shares valued at $151,236 were sold by Welgus Howard G. on Apr 01 ’25. At $15.12 per share, Welgus Howard G. sold 10,000 shares. The insider’s holdings dropped to 121,944 shares worth approximately $1.64 million following the completion of this transaction.
Also, Topper David Joseph sold 9,600 shares, netting a total of over 151,698 in proceeds. Following the sale of shares at $15.80 each, the insider now holds 182,774 shares.
Before that, Topper David Joseph had added 9,600 shares to its account. In a trade valued at $151,698, the Officer bought Arcutis Biotherapeutics Inc shares for $15.80 each.
As published in their initiating research note from H.C. Wainwright on December 30, 2024, Arcutis Biotherapeutics Inc [ARQT] has been a Buy and the price target has been revised to $19. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in late August. As of January 03, 2024, Mizuho has increased its “Neutral” rating to a “Buy” for ARQT. Earlier on October 26, 2023, Mizuho downgraded its rating. Their new recommendation was “a Neutral” for ARQT stock which previously was a “a Buy”.
Analyzing ARQT Stock Performance
During the last five days, there has been a drop of approximately -16.83%. Over the course of the year, Arcutis Biotherapeutics Inc shares have dropped approximately -3.52%. Shares of the company reached a 52-week high of $17.75 on 03/25/25 and a 52-week low of $11.13 on 02/11/25. A 50-day SMA is recorded $14.22, while a 200-day SMA reached $11.67.
Support And Resistance Levels for Arcutis Biotherapeutics Inc (ARQT)
According to the 24-hour chart, there is a support level at 12.87, which, if violated, would cause prices to drop to 12.30. In the upper region, resistance lies at 13.94. The next price resistance is at 14.44. RSI (Relative Strength Index) is 41.78 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -1.69, which suggests the price will decrease in the coming days. Percent R is at 78.36%, indicating bearish price movement. Stochastics %K at holding indicates that the stock is to be held.
